NHS Framework Agreement for Branded Medicines – Tranche B - NOFE & MAE and Eculizumab & Ravulizumab for London & SOFE - 01 September 2025
Awarded to Abbvie Ltd, Accord-UK Ltd, Alexion Pharmaceuticals +18 more
NHS England(buyer)
- Published
- Published 17 February 2025
- Deadline
- Closed 7 April 2025
Tender documents
Skim pulls every file the buyer attaches to this process and extracts the requirements from it.
Documents as they publish
Specification, evaluation criteria, pricing schedules and every requirement — extracted, searchable and mapped to your response.
Overview
Contracting authority
NHS England
BuyerLeeds, United Kingdom
Authority website ↗NHS England
BuyerLondon, United Kingdom
Authority website ↗
Find the key decision makers
The people who scope, score and sign this contract — names, roles and how to reach them.
Lots (2)
Lot 1 - CM/PHR/24/5680/01 - Tranche B for North of England and Midlands & East
Tranche B for North of England and Midlands & East. Period of Framework Agreement: 01 September 2025 to 31 August 2027. Additional information: Price is not the only award criterion and all criteria are stated in the procurement documents.
£2,848,328,000Lot 2 - CM/PHR/24/5680/02 - Eculizumab and Ravulizumab for London & SOFE
Eculizumab and Ravulizumab for London & SOFE. Additional information: Price is not the only award criterion and all criteria are stated in the procurement documents.
£26,389,000
Key details
- Country
- United Kingdom
- Status
- In delivery
- Category
- Goods
- Estimated value
- £4,108,145,000
- Procedure
- Open
- Contract type
- Framework agreement
- Published
- 17 February 2025
- Deadline
- Closed
Award outcome
- Awarded value
- £24
- Award date
- 30 June 2025
- Contract period
- 31 August 2025 → 31 August 2027
- Abbvie Ltd
- Accord-UK Ltd
- Alexion Pharmaceuticals
- Amgen Ltd
- Biogen
- Celltrion Healthcare United Kingdom Limited
- CuraTeQ Biologics s.r.o.
- Dr.Reddy's Laboratories (UK) Limited
- Fresenius Kabi Limited
- GlaxoSmithKline UK Limited
- Janssen-Cilag Ltd
- Organon Pharmaceuticals UK Ltd
- Orifarm UK
- Pfizer Ltd
- Roche Products Ltd
- Samsung Bioepis UK Ltd
- Sandoz Ltd
- Sobi (Swedish Orphan Biovitrum Ltd)
- Takeda UK Ltd
- Thornton and Ross Ltd
- Zentiva Pharma UK Ltd
Contract ending soon? Skim tracks incumbents and flags recompetes early. Start for Free to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract
29 July 2025
Contract Notice
17 February 2025
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
How to win this tender
Skim reads the notice and every document attached to it, scores the fit against your company profile for a clear bid or no-bid call, then drafts each answer from your own evidence and past bids. You review, refine and submit — on time, with every requirement covered.
See exactly how Skim’s agents do this →
Comparing platforms? Skim is set against the alternatives for pre-tender intelligence, tender management software and bid management software.
Find tenders like this before your competitors do.
Skim scans every portal daily and scores each tender against your profile. Start for free and see the tenders you are missing.